These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6538377)

  • 21. Cyclophosphamide and cortisol reduce the severity of morphine withdrawal.
    Montgomery SP; Dafny N
    Int J Immunopharmacol; 1987; 9(4):453-7. PubMed ID: 3623770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis of precipitated withdrawal in rats acutely dependent on morphine.
    Ramabadran K
    Jpn J Pharmacol; 1985 Apr; 37(4):307-16. PubMed ID: 2989597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
    Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
    Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central regulation of intestinal function: morphine withdrawal diarrhea.
    Schreier WA; Burks TF
    Proc West Pharmacol Soc; 1982; 25():151-4. PubMed ID: 6889739
    [No Abstract]   [Full Text] [Related]  

  • 25. Electroacupuncture treatment of morphine-dependent mice reduces signs of withdrawal, without showing cross-tolerance.
    Cheng RS; Pomeranz B; Yu G
    Eur J Pharmacol; 1980 Dec; 68(4):477-81. PubMed ID: 7193585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.
    Bhargava HN
    Psychopharmacology (Berl); 1976 Sep; 49(3):267-70. PubMed ID: 826944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C.
    Ohsawa M; Kamei J
    Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Activation of the spinal extracellular signal-regulated kinase is involved in morphine dependence and naloxone-precipitated withdrawal response].
    He JH; Cao JL; Xu YB; Song XS; Ding HL; Zeng YM
    Sheng Li Xue Bao; 2005 Oct; 57(5):557-65. PubMed ID: 16220193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome.
    Bhargava HN; Thorat SN
    Pharmacology; 1996 Feb; 52(2):86-91. PubMed ID: 8851629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on morphine. IX. On the intensity of the abstinence syndrome to morphine induced by daily injections of nalorphine in white mice.
    Huidobro F; Maggiolo C
    Arch Int Pharmacodyn Ther; 1965 Nov; 158(1):97-112. PubMed ID: 5892561
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute opioid physical dependence in humans: effect of naloxone at 6 and 24 hours postmorphine.
    Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
    Pharmacol Biochem Behav; 1990 Jun; 36(2):393-9. PubMed ID: 2356213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypothalamic self-stimulation during the abstinence syndrome in morphine-dependent rats].
    Zvartau EE
    Biull Eksp Biol Med; 1978 Mar; 85(3):304-7. PubMed ID: 566590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspects of abstinence after morphine ingestion.
    Rönnbäck L; Eriksson PS; Zeuchner J; Rosengren L; Wronski A
    Pharmacol Biochem Behav; 1987 Sep; 28(1):87-93. PubMed ID: 3659110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Different roles of the spinal protein kinase C alpha and gamma in morphine dependence and naloxone-precipitated withdrawal].
    Cao JL; Ding HL; He JH; Zhang LC; Wang JK; Zeng YM
    Sheng Li Xue Bao; 2005 Apr; 57(2):161-8. PubMed ID: 15830100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of histaminergic-noradrenergic axis in naloxone-induced withdrawal symptoms in mice.
    el Kadi AO; Sharif SI
    Pharmacol Biochem Behav; 1996 Sep; 55(1):49-54. PubMed ID: 8870037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats.
    Buccafusco JJ; Zhang LC; Shuster LC; Jonnala RR; Gattu M
    Brain Res; 2000 Jan; 852(1):76-83. PubMed ID: 10661498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical dependence on diazepam and lorazepam in the dog.
    McNicholas LF; Martin WR; Cherian S
    J Pharmacol Exp Ther; 1983 Sep; 226(3):783-9. PubMed ID: 6136601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradoxical absence of aggression during naloxone-precipitated morphine withdrawal.
    Gianutsos G; Hynes MD; Drawbaugh RB; Lal H
    Psychopharmacologia; 1975 Jul; 43(1):43-6. PubMed ID: 1172256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine abstinence syndrome in rabbits precipitated by injection of morphine antagonists into the ventricular system and restricted parts of it.
    Herz A; Teschemacher H; Albus K; Zieglgänsberger S
    Psychopharmacologia; 1972; 26(3):219-35. PubMed ID: 4677798
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of calcitonin on morphine tolerance and withdrawal syndrome in morphine physically dependent rats.
    Clementi G; Valerio C; Prato A; Caruso A; Patti F; Patanè S; Drago F
    Eur J Pharmacol; 1989 Apr; 163(1):175-9. PubMed ID: 2744091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.